Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oral gabapentin to reduce emergence agitation and delirium in adults after nasal surgery is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Cairo University | Conditions: Emergence Agitation | Phase 3 | Status: NOT_YET_RECRUITING